Cart
sales@molnova.com
SR1001
CAS No. 1335106-03-0
SR1001( —— )
Catalog No. M19942 CAS No. 1335106-03-0
SR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 260 | In Stock |
|
| 50MG | 475 | In Stock |
|
| 100MG | 680 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSR1001
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
-
DescriptionSR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargetROR
-
RecptorRORα| RORγ
-
Research AreaNeurological Disease
-
IndicationMultiple sclerosis
Chemical Information
-
CAS Number1335106-03-0
-
Formula Weight477.4
-
Molecular FormulaC15H13F6N3O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 45 mg/mL;Ethanol: 45 mg/mL;Water: Insoluble
-
SMILESCC(=O)Nc1nc(C)c(s1)S(=O)(=O)Nc1ccc(cc1)C(O)(C(F)(F)F)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Solt LA et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 2011 Apr 28;472(7344):491-4.
molnova catalog
related products
-
ML 209
ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).
-
XY018
XY018 is an orally available, selective and highly effective ROR-γ antagonist with antitumor activity, inhibits ROR-γ activity, inhibits tumor cell growth, and can be used to study drug-resistant prostate cancer.
-
AZD-0284
AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for the potential treatment of Plaque psoriasis.
